CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C20304 | BRD-K56258950 | BRD-K56258950 | -- | -- | -- | Details |
| C20305 | BRD-K56261053 | BRD-K56261053 | -- | -- | -- | Details |
| C20306 | BRD-K56261447 | BRD-K56261447 | -- | -- | -- | Details |
| C20307 | BRD-K56269643 | BRD-K56269643 | -- | -- | -- | Details |
| C20308 | BRD-K56272400 | BRD-K56272400 | -- | -- | -- | Details |
| C20309 | BRD-K56274797 | BRD-K56274797 | -- | -- | -- | Details |
| C20310 | BRD-K56276074 | BRD-K56276074 | -- | -- | -- | Details |
| C20311 | BRD-K56277358 | MGCD-265 | MET; AXL | VEGFR inhibitor | -- | Details |
| C20312 | BRD-K56283394 | BRD-K56283394 | -- | -- | -- | Details |
| C20313 | BRD-K56285711 | BRD-K56285711 | -- | -- | -- | Details |
| C20314 | BRD-K56287385 | ST-001903 | -- | -- | -- | Details |
| C20315 | BRD-K56291712 | voxtalisib | MTOR; PIK3CA | MTOR inhibitor; PI3K inhibitor | -- | Details |
| C20316 | BRD-K56298028 | BRD-K56298028 | -- | -- | -- | Details |
| C20317 | BRD-K56301217 | ABT-737 | BCL2; BCL2L1; BCL2L2 | BCL inhibitor | -- | Details |
| C20318 | BRD-K56301236 | BRD-K56301236 | -- | -- | -- | Details |
| C20319 | BRD-K56301498 | BRD-K56301498 | -- | -- | -- | Details |
| C20320 | BRD-K56304906 | BRD-K56304906 | -- | -- | -- | Details |
| C20321 | BRD-K56307118 | BRD-K56307118 | -- | -- | -- | Details |
| C20322 | BRD-K56309946 | BRD-K56309946 | -- | -- | -- | Details |
| C20323 | BRD-K56322026 | BRD-K56322026 | -- | -- | -- | Details |
| C20324 | BRD-K56325098 | BRD-K56325098 | -- | -- | -- | Details |
| C20325 | BRD-K56327795 | BRD-K56327795 | -- | -- | -- | Details |
| C20326 | BRD-K56328447 | BRD-K56328447 | -- | -- | -- | Details |
| C20327 | BRD-K56332068 | BRD-K56332068 | -- | -- | -- | Details |
| C20328 | BRD-K56334280 | amonafide | TOP2A | Topoisomerase inhibitor | -- | Details |
| C20329 | BRD-K56336567 | BRD-K56336567 | -- | -- | -- | Details |
| C20330 | BRD-K56339035 | BRD-K56339035 | -- | -- | -- | Details |
| C20331 | BRD-K56341841 | BRD-K56341841 | -- | -- | -- | Details |
| C20332 | BRD-K56343202 | BRD-K56343202 | -- | -- | -- | Details |
| C20333 | BRD-K56343971 | vemurafenib | BRAF | RAF inhibitor | -- | Details |
| C20334 | BRD-K56345641 | BRD-K56345641 | -- | -- | -- | Details |
| C20335 | BRD-K56348092 | BRD-K56348092 | -- | -- | -- | Details |
| C20336 | BRD-K56349799 | BRD-K56349799 | -- | -- | -- | Details |
| C20337 | BRD-K56351525 | BRD-K56351525 | -- | -- | -- | Details |
| C20338 | BRD-K56354139 | BRD-K56354139 | -- | -- | -- | Details |
| C20339 | BRD-K56357490 | BRD-K56357490 | -- | -- | -- | Details |
| C20340 | BRD-K56366698 | BRD-K56366698 | -- | -- | -- | Details |
| C20341 | BRD-K56367200 | BRD-K56367200 | -- | -- | -- | Details |
| C20342 | BRD-K56370195 | BRD-K56370195 | -- | -- | -- | Details |
| C20343 | BRD-K56373119 | BRD-K56373119 | -- | -- | -- | Details |
| C20344 | BRD-K56375979 | BRD-K56375979 | -- | -- | -- | Details |
| C20345 | BRD-K56379049 | BRD-K56379049 | -- | -- | -- | Details |
| C20346 | BRD-K56379651 | BRD-K56379651 | -- | -- | -- | Details |
| C20347 | BRD-K56381552 | BRD-K56381552 | -- | -- | -- | Details |
| C20348 | BRD-K56384660 | BRD-K56384660 | -- | -- | -- | Details |
| C20349 | BRD-K56384677 | BRD-K56384677 | -- | -- | methyl 8-fluoro-4H-thieno[3,2-c]chromene-2-carboxylate | Details |
| C20350 | BRD-K56384721 | BRD-K56384721 | -- | -- | -- | Details |
| C20351 | BRD-K56392985 | BRD-K56392985 | -- | -- | -- | Details |
| C20352 | BRD-K56395592 | BRD-K56395592 | -- | -- | -- | Details |
| C20353 | BRD-K56398628 | BRD-K56398628 | -- | -- | -- | Details |
| C20354 | BRD-K56399425 | BRD-K56399425 | -- | -- | -- | Details |
| C20355 | BRD-K56401968 | BRD-K56401968 | -- | -- | -- | Details |
| C20356 | BRD-K56403959 | ZK-756326 | CCR8 | CCK receptor ligand | -- | Details |
| C20357 | BRD-K56405136 | BRD-K56405136 | -- | -- | -- | Details |
| C20358 | BRD-K56405753 | MK-2461 | FGFR1; FGFR3; FGFR2; FLT1; FLT3; MET | FGFR inhibitor; VEGFR inhibitor | -- | Details |
| C20359 | BRD-K56408846 | BRD-K56408846 | -- | -- | -- | Details |
| C20360 | BRD-K56411643 | BRD-K56411643 | -- | -- | -- | Details |
| C20361 | BRD-K56415410 | BRD-K56415410 | -- | -- | -- | Details |
| C20362 | BRD-K56417082 | BRD-K56417082 | -- | -- | -- | Details |
| C20363 | BRD-K56417931 | BRD-K56417931 | -- | -- | -- | Details |
| C20364 | BRD-K56424158 | BRD-K56424158 | -- | -- | -- | Details |
| C20365 | BRD-K56426074 | BRD-K56426074 | -- | -- | -- | Details |
| C20366 | BRD-K56427898 | BRD-K56427898 | -- | -- | -- | Details |
| C20367 | BRD-K56428170 | BRD-K56428170 | -- | -- | -- | Details |
| C20368 | BRD-K56429665 | calcipotriol | VDR | Vitamin D receptor agonist | -- | Details |
| C20369 | BRD-K56431031 | BRD-K56431031 | -- | -- | -- | Details |
| C20370 | BRD-K56437119 | BRD-K56437119 | -- | -- | -- | Details |
| C20371 | BRD-K56441027 | BRD-K56441027 | -- | -- | -- | Details |
| C20372 | BRD-K56446541 | BRD-K56446541 | -- | -- | -- | Details |
| C20373 | BRD-K56450018 | BRD-K56450018 | -- | -- | -- | Details |
| C20374 | BRD-K56450366 | NSC-94258 | -- | -- | -- | Details |
| C20375 | BRD-K56452877 | BRD-K56452877 | -- | -- | -- | Details |
| C20376 | BRD-K56469794 | BRD-K56469794 | -- | -- | 2-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine | Details |
| C20377 | BRD-K56470219 | BRD-K56470219 | -- | -- | -- | Details |
| C20378 | BRD-K56473018 | BRD-K56473018 | -- | -- | -- | Details |
| C20379 | BRD-K56477805 | BRD-K56477805 | -- | -- | -- | Details |
| C20380 | BRD-K56478238 | P-1075 | KCNJ11 | ATP channel activator; Potassium channel activator | -- | Details |
| C20381 | BRD-K56482508 | BRD-K56482508 | -- | -- | -- | Details |
| C20382 | BRD-K56483755 | BRD-K56483755 | -- | -- | -- | Details |
| C20383 | BRD-K56483981 | BRD-K56483981 | -- | -- | chicago-sky-blue-6b | Details |
| C20384 | BRD-K56488838 | BRD-K56488838 | -- | -- | -- | Details |
| C20385 | BRD-K56489029 | BRD-K56489029 | -- | -- | -- | Details |
| C20386 | BRD-K56505861 | BRD-K56505861 | -- | -- | -- | Details |
| C20387 | BRD-K56509348 | BMS-182874 | EDNRA | Endothelin receptor antagonist | -- | Details |
| C20388 | BRD-K56515112 | medrysone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C20389 | BRD-K56518176 | BRD-K56518176 | -- | -- | -- | Details |
| C20390 | BRD-K56520129 | BRD-K56520129 | -- | -- | -- | Details |
| C20391 | BRD-K56520530 | BRD-K56520530 | -- | -- | -- | Details |
| C20392 | BRD-K56520977 | BRD-K56520977 | -- | -- | -- | Details |
| C20393 | BRD-K56525823 | BRD-K56525823 | -- | -- | -- | Details |
| C20394 | BRD-K56531121 | BRD-K56531121 | -- | -- | -- | Details |
| C20395 | BRD-K56535275 | BRD-K56535275 | -- | -- | -- | Details |
| C20396 | BRD-K56536241 | BRD-K56536241 | -- | -- | -- | Details |
| C20397 | BRD-K56536691 | BRD-K56536691 | -- | -- | -- | Details |
| C20398 | BRD-K56553629 | BRD-K56553629 | -- | -- | -- | Details |
| C20399 | BRD-K56555032 | BRD-K56555032 | -- | -- | -- | Details |
| C20400 | BRD-K56558538 | ambroxol | CYP3A4 | Sodium channel blocker | -- | Details |
| C20401 | BRD-K56562216 | BRD-K56562216 | -- | -- | -- | Details |
| C20402 | BRD-K56562541 | BRD-K56562541 | -- | -- | -- | Details |
| C20403 | BRD-K56563145 | BRD-K56563145 | -- | -- | -- | Details |